Good MorningSummer trading has been unusually punishing, with thin liquidity magnifying every disappointment and driving quality stocks into deep pullbacks. Investors still believe in the AI buildout, but they now demand visible revenue, margins, and cash flow before rewarding higher spending.
Last week showed how selective the market has become. Microsoft and Amazon strengthened confidence by linking AI investment to growth, while Meta slipped because heavier spending lacked equally convincing monetization. The Fed was the lone macro driver, briefly unsettling positioning before buyers defended support, reinforcing the view that durable earnings quality matters more than broad risk appetite.
This week shifts fully to what comes next. SpaceX reports Tuesday, with Starlink demand, cash burn, and operating plans shaping whether investors can look beyond valuation concerns. AMD follows with a pivotal test of MI450 and Helios demand, future revenue visibility, and its ability to challenge NVIDIA in inference. Bloom Energy must show data-center power demand converting into cash flow, while Cloudflare needs to prove AI traffic can support durable monetization. Featured: While NASDAQ prices in fantasy, prepared investors are moving (Ad) 
|
Markets | |
Fixed-income exchange-traded funds (ETFs) have quietly built up significant inflows this year, a sign that investors are looking for income without having to make an aggressive bet on falling interest rates. These funds have drawn about $300 billion in new investments since the start of 2026, a num... Read the Full Story |
|
From Our Partners | | Nvidia CEO Jensen Huang says Elon Musk's $119 billion plan will be extremely hard to pull off.
Larry Benedict, who ran a $900 million hedge fund and posted 20 consecutive years without a loss, including over $274 million in audited net income between 2004 and 2012, says one long forgotten American company already holds what Musk needs.
Get the ticker and his full analysis before the November 30 deadline. | | Click here to get the free ticker before November 30 |
|
Healthcare | |
AbbVie (NYSE: ABBV) isn’t what it once was, a one-trick pony dependent on Humira. Today, AbbVie is a well-diversified business with numerous blockbusters. No longer dependent on a single product or segment, the company has nimbly moved past its patent cliff and is on track to sustain growth and, mo... Read the Full Story |
|
Materials | |
Rio Tinto (NYSE: RIO) just delivered a first-half report with numbers that back up a broader thesis rooted in a major shift. Physical assets are entering a multi-year period of outperformance. Higher bond yields, oil supply anxieties, and an artificial intelligence (AI) infrastructure buildout are ... Read the Full Story |
|
|
Technology | |
Strategy Inc (NASDAQ: MSTR) recently reported a heavy $8.22 billion second-quarter net loss, translating to a stark negative earnings per share of $24.45.
For a conventional enterprise software vendor, a deficit of that scale would signal catastrophic operational failure. But applying traditional ... Read the Full Story |
|
Markets | |
While fear and panic have gripped the AI trade and broader technology sector, one corner of the market has recently made new 52-week highs. The Financial Select Sector SPDR Fund (NYSEARCA: XLF) recently touched a fresh all-time high of $57.60 before easing back into the mid-$50s.
Over the past mont... Read the Full Story |
|
From Our Partners | | Small-cap moves rarely announce themselves. Street Ideas surfaces quiet setups with real momentum before they appear on mainstream radars.
With tomorrow's open approaching, three names are already showing early activity worth a closer look. Get the alerts that keep you ahead of the crowd. | | Join Street Ideas - Get Your Free Report Sent To Your Email |
|
Communication Services | |
It's not often that a company posting record revenue finds its stock sinking to a 52-week low, but that's exactly the position Netflix Inc. (NASDAQ: NFLX) found itself in after its latest earnings report.
Earlier this month, the streaming giant delivered a quarter that, on its face, looked solid, ... Read the Full Story |
|
Finance | |
Recent results from Popular (NASDAQ: BPOP), Puerto Rico's largest bank, are showing why analysts rate the bank a solid Buy.
The midsized bank is steadily growing earnings, returning capital to shareholders, and hitting ratios that would make many other banks jealous. Shareholders are also likely to... Read the Full Story |
|
Industrials | |
Swiss engineering and automation company ABB Ltd. (OTCMKTS: ABBNY) may not figure prominently in many U.S. investors' plans, but its recent $5.5-billion acquisition of Rotork—the largest in the company's history—could change things. ABB paid a hefty premium for the smaller firm, known for its niche... Read the Full Story |
|
Healthcare | |
Hospitals are finally buying heavy iron again. After years of delayed capital expenditures due to pandemic hangovers and supply chain shocks, healthcare infrastructure is quietly undergoing a structural upgrade cycle. GE HealthCare Technologies (NASDAQ: GEHC) just delivered the clearest evidence ye... Read the Full Story |
|
Communication Services | |
The commercial space sector is undergoing a profound and necessary transition. For years, the narrative of interplanetary expansion and global satellite constellations fueled a growth-at-all-costs euphoria on Wall Street. Investors poured capital into aerospace sector ventures based on distant proj... Read the Full Story |
|
Monday's Early Bird Stock Of The Day Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. The company was incorporated in 1980 and is headquartered in Fremont, California. | Should I Buy Lam Research Stock? LRCX Bull and Bear Case Explained
These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Lam Research was last updated on Saturday, October 31, 2026 at 6:32 PM.
Lam Research Bull Case -
Lam Research Co. recently reported earnings per share of $2.20 for the quarter, which beat the analyst consensus estimate of $2.18, demonstrating strong operational performance and profitability that exceeds market expectations.
-
The company's revenue reached $8.22 billion during the most recent quarter, representing a significant year-over-year growth of 54.4%, which indicates robust demand for its semiconductor processing equipment and strong market positioning.
-
Wall Street analysts maintain a consensus rating of Moderate Buy with a target price of $360.23, suggesting that the current stock price of $239.11 offers substantial upside potential for investors looking to capitalize on the firm's growth trajectory.
-
Lam Research Co. recently increased its quarterly dividend to $0.33 per share, up from the previous $0.26, signaling management confidence in future cash flows and providing a growing income stream for shareholders.
-
The company maintains a healthy financial position with a current ratio of 2.48 and a quick ratio of 1.86, indicating strong liquidity and the ability to meet short-term obligations without relying on inventory sales.
Lam Research Bear Case -
The stock has experienced a significant decline, trading at $239.11, which is well below its 52-week high of $438.50 and even below its 50-day simple moving average of $294.47, indicating recent downward momentum and potential overvaluation correction.
-
Corporate insiders have been consistently selling shares, with recent transactions including Director Bethany Mayer selling 9,557 shares and Insider Ava Harter selling 5,000 shares, which may signal a lack of confidence in the stock's near-term appreciation.
-
The company carries a high beta of 1.85, meaning its stock price is significantly more volatile than the overall market, exposing investors to greater risk of sharp price swings during market downturns.
-
Short interest has increased slightly to 28,325,154 shares, with a days-to-cover ratio of 3.59, suggesting that a notable portion of the market is betting against the stock's performance, which could lead to further selling pressure.
-
Some institutional investors, such as Modera Wealth Management LLC, have reduced their stakes in the company, with Modera selling 4,988 shares during the third quarter, indicating a shift in institutional sentiment away from the stock.
| | View Today's Stock Pick |
|
